01/09/2015 22:25:50 Free Membership Login

   

AMAG Pharmaceuticals Inc

Visual Financials
Company Name: AMAG Pharmaceuticals Inc
Ticker Symbol: AMAG
CIK Number: 0000792977
WWW Address: http://www.amagpharma.com
CEO: William K. Heiden
No. of Employees: 257
Common Issue Type: CS
Business Description:AMAG Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of Feraheme® (ferumoxytol) Injection for Intravenous, or IV, use to treat iron deficiency anemia, or IDA.

 
Industry Information: DRUGS - Diagnostic Support [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 61.02 Down -1.52 60.0 66.43 61.19 62.97 60.31 1127762
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,887.1 30.9 0.00 6.06 0.00 10.9 0.0 77.73 - 22.42
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close60.98$
PE Ratio - LTM10.9
Market Capitalisation1,887.1mil
Latest Shares Outstanding30.9mil
Earnings pS (EPS)6.06$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee483,984$
Effective Tax Rate0.0%
Float25.9mil
Float as % of Shares Outstanding0.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.60%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin83.7%
EBITDA Margin3.5%
Pre-Tax Profit Margin0.0%
Assets Turnover15.0%
Return on Assets (ROA)16.4%
Return on Equity (ROE)43.0%
Return on Capital Invested (ROCI)17.8%
Current Ratio1.6
Leverage Ratio (Assets/Equity)3.0
Interest Cover-0.2
Total Debt/Equity (Gearing Ratio)1.08
LT Debt/Total Capital50.0%
Working Capital pS3.48$
Cash pS0.00$
Book-Value pS23.05$
Tangible Book-Value pS-20.49$
Cash Flow pS2.69$
Free Cash Flow pS2.67$
KEY FIGURES (LTM): Price info
Price/Book Ratio2.86
Price/Tangible Book Ratio0.00
Price/Cash Flow24.4
Price/Free Cash Flow24.6
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---6.14718,0761,792,317
4 Weeks70.4052.7167.11-6.82664,98613,964,708
13 Weeks77.7352.7167.74-7.72685,14144,534,224
26 Weeks77.7347.8849.1627.237746,50496,299,107
52 Weeks77.7322.4222.76174.8179659,004168,046,181
YTD77.7338.25-46.854733,989124,778,264
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
63.6962.0967.5760.4555.610.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.490.70.27
Income0.0
Dividend0.0
Capital SpendingNA
R&D7.24NA-7.95
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %15.515.539.4
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.400.402.86
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio7.74
Current Ratio1.6
Quick Ratio (Acid Test)1.1
Liquidity Ratio (Cash)1.58
Receivables Turnover5.5
Average Collection Period65
Working Capital/Equity23.4
Working Capital pS4.20
Cash-Flow pS0.45
Free Cash-Flow pS0.45
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.64
Financial Leverage Ratio (Assets/Equity)1.1
Debt Ratio35.7
Total Debt/Equity (Gearing Ratio)1.08
LT Debt/Equity1.00
LT Debt/Capital Invested79.8
LT Debt/Total Liabilities93.1
Interest Cover-0.2
Interest/Capital Invested1.20
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.47
Current P/E Ratio - LTM10.90
Enterprise Value (EV)/EBITDA622.72
Enterprise Value (EV)/Free Cash Flow168.40
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM2.86
Price/Cash Flow Ratio24.4
Price/Free Cash Flow Ratio - LTM24.6
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio14.1
5-Y Low P/E Ratio2.3
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E46
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS29.69
Current Liabilities pS10.71
Tangible Book Value pS - LTM-20.49
Book Value pS - LTM23.05
Capital Invested pS30.89
Cash pS - LTM0.00
Cash Flow pS - LTM2.69
Free Cash Flow pS - LTM2.67
Earnings pS (EPS)6.06
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin9.06
Free Cash Flow Margin 5YEAR AVG-22.38
Net Profit Margin1.2
Net Profit Margin - 5YEAR AVRG.-0.3
Equity Productivity0.27
Return on Equity (ROE)0.4
Return on Equity (ROE) - 5YEAR AVRG.-0.1
Capital Invested Productivity0.13
Return on Capital Invested (ROCI)-0.2
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.2
Assets Productivity0.20
Return on Assets (ROA)0.2
Return on Assets (ROA) - 5YEAR AVRG.-0.1
Gross Profit Margin83.7
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM3.5
EBIT Margin - LTM-2.1
Pre-Tax Profit Margin-0.6
Pre-Tax Profit Margin - 5YEAR AVRG.-0.6
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.1.4
EFFICIENCY RATIOS
Cash Conversion Cycle646,369
Revenue per Employee483,984
Net Income per Employee528,471
Average Collection Period646,369
Receivables Turnover5.5
Day's Inventory Turnover Ratio
Inventory Turnover0.7
Inventory/Sales32.6
Accounts Payble/Sales5.87
Assets/Revenue5.00
Net Working Capital Turnover1.16
Fixed Assets Turnover0.11
Total Assets Turnover0.2
Revenue per $ Cash1.04
Revenue per $ Plant81.89
Revenue per $ Common Equity0.27
Revenue per $ Capital Invested0.13
Selling, General & Adm/tive (SG&A) as % of Revenue58.1
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue19.4
R&D Expense as % of Revenue - 5YEAR AVRG.19.4

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq amag150901 22:25